Perinatal infections CMV HSV Syphillis Rubella Toxoplasmosis Flashcards

1
Q

What public health intervention should be taken to combat congenital CMV infection? Justify your answer.

A
  • All women should receive advice on CMV during routine antenatal care
  • Avoid kissing small children on the mouth
  • Wash hands regularly, and especially after wiping the nose, mouth or toileting young children
  • Wash surfaces with antibacterial after contact with urine/saliva of small children
  • Do not share food or drink utensils
  • Don’t put dummies into the mouth
  • There is no evidence for routine serological screening during scheduled antenatal care

Justification

  • Children under 3 years old are particularly likely to excrete virus, and at a higher titre than adults
  • This risk is increased if they go to day care
  • They excrete virus in urine and saliva
  • Both primary and secondary infections (reinfection), or reactivation, can result in transmission to the fetus and potentially cause congenital CMV
  • Though transmission to the fetus is less in secondary infection or reactivation as compared to primary infection (1-3% vs 30-40%), the rate of seropositivity (and hence latent phase of infection) in the the Australian population is 40-60%, and the largest burden of congenial CMV is attributed to secondary infection/reactivation
  • Consequently any public health approach needs to target all women, regardless of their existing CMV serological status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the transmission of CMV, and the risk for congenital CMV.

A

Primary CMV: 30-40%
Reactivation: 1-3% transmission risk
1st trimester infection: neurodisability risk higher
2nd/3rd: acute visceral disease more likely

  • The mother often contracts CMV from other children (particularly under 3 years, or attending day care); it can be transmitted in their urine or saliva
  • Adults transmit CMV from the cervix, semen and other bodily fluids
  • It can be contracted from direct contact with infected fluid, or via fomites
  • Transmission to the fetus is across the placenta, or can be during or after delivery
  • The highest risk of transmission to the fetus is during primary infection in the first trimester, when the risk is 30-40%; roughly 1/3 will develop symptoms of congenital CMV (10% overall)
  • The risk of transmission to the fetus in secondary infection or reactivation is 1-3%; however, once infected, the risk of morbidity and mortality is comparable to during primary infection
  • 90% foetuses will have no signs/symptoms of congenital CMV at birth; however 10-15% of these may develop longer term sequelae in early childhood (SNHL, chorioretinitis most common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A woman who is 24 weeks pregnant presents acutely with flu-like symptoms, a fever, and cervical lymphadenopathy. Describe your approach to screening and diagnosing possible congenital CMV in this case.

A
  • History
  • Examination
  • Serological testing (CMV IgM, IgG …+/- IgG specific avidity)
  • USS findings +/- MRI
  • Amniocentesis and CMV nucleic acid PCR- 6-8 weeks after infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the interpretation of different CMV serological results

A

IgM -, IgG - = no previous CMV, still susceptible
IgM -, IgG + = Previous CMV infection, no current infection
IgM +, IgG - = false positive IgM, or possible early primary infection; repeat test in 2 weeks
IgM +, IgG +, low IgG avidity = Primary infection within last 3 months
IgM +, IgG +, intermediate IgG avidity = Possible primary infection within last 3 months - manage as acute primary infection
IgM +, IgG +, high IgG avidity = Infection > 3months, reinfection or reactivation

Retrospective assessment of booking bloods can also be helpful to determine a primary infection, by demonstrating seroconversion within the pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What investigations can be used to diagnosis congenital CMV?

A

Maternal Serology
USS +/- MRI of head
Amniocentesis
- Ideally after 21wks gestation and >8 weeks after acute infection for best sensitivity and specificity (high false negative <21 wks gestation)
CMV testing on saliva or urine within first 3 wks of birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the management for babies affected by congenital CMV?

A

Antenatal:

  • Refer to MFM specialist
  • Serial US for growth monitoring
  • MRI to assess for congenital abnormality, particularly intracranial and neurological defects
  • If US and MRI are normal, there is a very good prognosis

After birth:

  • Newborn hearing assessment
  • Ophthalmology and head USS +/- MRI after birth
  • Referral to paediatric with specialist interest in congenital CMV
  • 3-6 monthly review for first 2 years of life, including hearing and neurodevelopment assessment
  • Treatment dependent on level and site of organ involvement
  • IV ganciclovir for 6 weeks or oral valganciclovir for up to 6 months has demonstrated some benefits in improving hearing and neurological outcomes at 6 and 12 months
  • Breast feeding should be encouraged, there is no evidence that transmission after birth has any significant sequelae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the findings and sequelae associated with congenital CMV infection?

A
  • SGA
  • polyhydramnios or oligohydramnios
  • microcephaly
  • Intracerebral calcification
  • ascites/hydrops
  • chorioretinitis
  • hepatosplenomegaly
  • anaemia/thrombocytopenia
  • still birth and neonatal death

Long term sequelae:

  • sensorineural hearing loss (not always present at birth)
  • cerebral palsy
  • developmental delay
  • visual impairment
  • Poor school performance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What 3 infections can be transmitted in utero and cause congenital defects?

A
  • CMV
  • Rubella
  • VZV (chicken pox)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the prevalence of CMV congenital infection?

A
      • 2.2% pregnancies

- It is the commonest of congenital infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes toxoplasmosis and how is it transmitted?

A
  • Toxoplasmosis Gondii (a protozoan parasite)
  • Common gut parasite in cats (can be in any animal); after ingesting infected food cats excrete oocysts in their faeces for several weeks - kittens tend to shed highest numbers due to primary infection
  • Transmission to humans is food borne (contaminated, undercooked food or poor food hygiene during preparation); zoonoses via cat faeces; congenital vertical transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the presentation of toxoplasmosis in adults?

A
  • In the adult most are asymptomatic; 10% get flu-like illness, fever, cervical lymphadenopathy, chorioretinitis
  • After acute infection it remains in the body in an inactive state, which can be reactivated during times of immune suppression
  • Severe presentations are common in the immune compromised and can be reactivated during immune suppression; pneumonitis, myocarditis and encephalitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the sequelae of congenital toxoplasmosis?

A
  • Can cause miscarriage, stillbirth and neonatal death
  • Majority of babies born with toxoplasmosis are asymptomatic
  • 10% of affected babies are born with chorioretinitis and blindness
  • 20% have generalised disease: hepatosplenomegaly, anaemia, jaundice, neurological symptoms and seizures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In congenital toxoplasmosis, what are the risks to the fetus in each trimester?

A

If the mother is immune (20-35% reproductive population), the risks of transmission and significant sequelae are low.

First trimester

  • Low risk MTFT (4-15%)
  • High risk of morbidity/mortality

Second trimester

  • Intermediate risk MTFT (25-40%)
  • Intermediate risk of morbidity/mortality

Third trimester

  • High risk MTFT (30-75%)
  • Low risk of morbidity/mortality; majority born without symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is toxoplasmosis diagnosed in pregnancy?

A
  • Maternal serology
  • USS +/- MRI - poor sensitivity and specificity
  • Amniocentesis and T.Gondii PCR (>4 weeks after acute infection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Once confirmed, what are the management options for toxoplasmosis infection during pregnancy?

A
  • Termination of pregnancy
  • Pyrimethamine and sulfadiazine from 18 weeks gestation ( with folinic acid)
  • Full examination after birth, with ophthalmology and hearing review, head USS +/-MRI, fetal serology IgA/IgM, T.Gondii PCR
  • If any of the above are abnormal, the infant should be treated with 12 months of pyrimethamine and sulfadiazine with folinic acid; they will require ongoing monitoring of vision, hearing and neurodevelopment delay through early childhood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which 3 congenital infections are most strongly associated with SGA?

A

CMV, rubella, syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the sequelae of congenital syphilis?

A
Saddle nose, 
interstitial keratitis, 
Hutchinsons incisors, 
sensorineural deafness, 
CN palsies, 
learning difficulties, 
Cluttons joint (arthritis typically affecting the knees)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does gestation affect the risk of birth defects with congenital rubella syndrome?

A

The greatest risk is within the first 16 weeks gestation. Between 16-20 wks low risk of deafness only. After 20 wks the risk of congenital abnormality is minimal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Interpret this routine antenatal serology screen and discuss its implications and management?
- Rubella IgM positive, Rubella IgG negative

A
  • This may be a non-specific IgM rise, or could be an acute infection
  • Repeat serology in 1-2 weeks to check for IgG seroconversion
  • If there is no evidence of seroconversion it is likely a false positive
  • If seroconversion occurs maternal infection is confirmed and the mother requires counselling based on the pregnancy gestation
20
Q

How is congenital rubella investigated and diagnosed?

A
  • History of rash-like illness or contact with suspected/confirmed rubella case
  • USS findings: SGA, cardiac defects (VSD, pulmonary stenosis), echogenic bowel, eye defects
21
Q

What management can be offered for congenital rubella syndrome?

A
  • Maternal infection in first trimester should be offered termination due to high risk congenital defects (85%)
  • Maternal infection in the second trimester - offer fetal testing (CVS or amniocentesis for rubella PCR, culture and fetal IgM). This should occur >6wks after maternal infection and after 20wk gestation to avoid false negatives
  • Maternal infection in the third trimester is very rarely associated with congenital defects so no treatment is required
  • Affected pregnancies should have neonatal screening - checking for signs of congenital rubella, cardiac/opthalmology/hearing screening, serology, urine and throat swabs for rubella PCR +/- culture
22
Q

How is syphilis diagnosed?

A
  • Syphilis serology
    (EIA or TPPA detects IgG and IgM, is specific for syphilis, but will remain positive once infected, even if fully treated; VDRL or RPR, non-specific, measured as a titre, positivity suggests ongoing infection requiring treatment)
  • Swab lesions for syphilis PCR or dark ground microscopy for treponemes
23
Q

How is syphilis treated in each trimester of pregnancy?

A
  • 1st & 2nd trimester 2.4MU benzathine benzylpenicillin IM (single dose)
  • 3rd trimester 2.4MU benzathine benzylpenicillin IM (2 doses, 1 week apart)
  • Tertiary syphilis requires 2.4MU benzathine benzylpenicillin IM (3 doses, 1 week apart)
  • Serology should be repeated monthly till delivery, and 3, 6, 12 months from treatment)
24
Q

What advice would you give a pregnant woman with recurrent genital herpes?

A
  • Offer prophylactic acyclovir from 36 weeks
  • Advise even with active lesions at the time of delivery the risk of transmission to the baby is low 1-3%
  • If she has active lesions at the time of delivery, she would have the option of caesarean delivery, though routinely vaginal birth is considered safe
  • If has PROM augment with syntocin
  • Invasive procedures (FSE/FBS) do not need to be avoided if indicated
25
Q

How would you manage a woman with the first episode of genital herpes in her current pregnancy?

A
  • Manage acute episode with 5 day course acyclovir / valaciclovir
  • Do type specific serology to check if acute infection
  • Prophylactic acyclovir from 36 weeks
  • If active lesions within 6 weeks of delivery offer an elective caesarean
  • If active lesions at time of delivery requires caesarean
  • If vaginal birth desired, give will require acyclovir in labour
  • Inform neonatologist, the baby may require treatment with acyclovir after delivery
26
Q

A pregnant woman presents with an ulcer in pregnancy, you suspect HSV. What investigations do you do?

A
  • decide if first or recurrent presentation.
  • If first presentation then need to do viral PCR to determine correct diagnosis and if HSV 1 or 2.
  • Test blood serology to confirm first presentation (IgG result negative but positive swab).
  • Counsel re risk
  • Prophylactic aciclovir (400mg TDS) from 36/40 (and treat lesion)
  • CS if primary lesion >34/40
27
Q

Risks of transmission of HSV:

Active recurrent infection at time of delivery, HSV 1

A

• 15%

28
Q

Risks of transmission of HSV:

Recurrent HSV2

A

<0.01% HSV2

Overall quote is 1-3% risk if combining HSV 1 and 2 risk

29
Q

Risks of transmission of HSV:

Active primary infection at time of delivery

A

25-50%

30
Q

• Indications for CS for HSV:

A

primary lesion in third trimester or seen at time of delivery.

If active lesion but recurrence- discussion with woman necessary based on risks.

• Avoid FSE/instrumental/FBS

31
Q

Management of baby if HSV suspected at time of delivery

A

o Asymptomatic and low risk (ie recurrent infection or seroconversion 6/52 before delivery)- observe and monitor for signs of infection

o Asymptomatic and high risk OR symptomatic- viral screen (LP, swabs, serology etc) and start acyclovir treatment

32
Q

Risks of transmission of HSV:

Primary infection in pregnancy but seroconversion well before delivery (ie before 36/40)

A

Same risk as recurrent HSV

33
Q

Neonatal signs/symptoms of HSV infection

A
Vesicular skin lesions or atypical
pustular or bullous lesions,
especially on presenting part
(note: may be absent)
• Seizures
• Unexplained sepsis with -ve blood
cultures not responding to antibiotics
• Low platelets
• Elevated LFTs
• DIC (disseminated intravascular
coagulation)
• Respiratory distress
(after day 1 of life)
• Corneal ulcer/keratitis
34
Q

What causes syphillis?

A

Bacteria- Treponema Pallidum

35
Q

What are the stages of syphillis? And risk of transmission to fetus?

A

Primary: Chancre. High risk

Secondary: Systemic illness including but not limited to fever, rash, hepatitis, lymphadenopathy, meningoencephalitis. Medium risk

LatentL Asymptomatic: <2 years-early; >2 years-late, Low risk

Tertiary: Cardiovascular, Neurological, Gummatous lesions. Risk: negligible.

36
Q

Treatment of syphillis according to stage:

A
Early syphilis (primary, secondary or early latent syphilis) treatment:
– Benzathine penicillin 1.8g (= 2.4 million units) IM, as a single dose OR
– Procaine penicillin 1.5g IM, daily for 10 days

Late syphilis (>2 years or unknown duration) treatment:
– Benzathine penicillin 1.8g (= 2.4 million units) IM, once weekly for 3 weeks OR
– Procaine penicillin 1.5g IM, daily for 15 days

37
Q

Syphillis: Investigations of the neonate

A
  • Infant serology
  • Neonatal examination: rash, mucosal lesions, hepatomegaly, nasal discharge, bony tenderness,
    eye lesions
  • Placental histopathology +/- PCR
38
Q

Syphilis: Next steps if initial investigations of the neonate are negative?

A

Repeat again at 3 and 6 months

If remain negative then can be confident that no infection

39
Q

Syphillis: General management of neonate if suspicion of congenital syphillis?

A

IV ben pen for 10/7

Then:

Follow up serology 1, 2, 4, 6, 12
months of age or until non reactive
on 2 occasions. If neurosyphilis
repeat CSF examination at 6 months

40
Q

Syphillis- alternatives to Ben Pen and their challenges?

A

Erythromycin- but doesn’t cross placenta

Ceftriaxone

41
Q

Risks of syphillis

A
Stillbirth 
Early fetal death 
LBW
Prematurity 
Congenital infection
42
Q

What do RPR tests show?

A

Non-treponemal test
Detect anti lipid IgM or IgG antibodies
Present in other diseases so not specific for syphilis and can give false positive results

43
Q

Downside of non-treponemal tests?

A
  • Not specific so can produce false positives
  • May be negative for up to four weeks after the
    lesion of primary syphilis first appears and can be
    negative in late latent syphilis;
    -In primary and secondary syphilis, these tests may be false negative due to a prozone reaction

Therefore may require repeat testing at 2 and 4 weeks

If still negative after 3/12 then syphillis not present

44
Q

What can non-treponemal tests be used for in addition to diagnosis?

A

Quantitative tests give a titre that can be used to calculate a response to treatment

45
Q

What is the use of treponemal tests?

A

Specific to syphilis but don’t differentiate venereal from endemic syphillis

Typically used as a confirmatory test once a non-treponemal test is positive

May stay positive for a lifetime

Example: TPPA